STRS Ohio’s Verrica Pharmaceuticals VRCA Stock Holding History

STRS Ohio’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30	Closed	-$2K	–	2307
2022 Q1	$2K	Hold	30	–	–	﹤0.01%	2127
2021 Q4	$2K	Hold	30	–	–	﹤0.01%	2175
2021 Q3	$3K	Hold	30	–	–	﹤0.01%	2222
2021 Q2	$3K	Hold	30	–	–	﹤0.01%	2215
2021 Q1	$4K	Hold	30	–	–	﹤0.01%	2151
2020 Q4	$3K	Hold	30	–	–	﹤0.01%	2146
2020 Q3	$2K	Sell	30 -140	-82%	-$11.5K	﹤0.01%	2172
2020 Q2	$18K	Hold	170	–	–	﹤0.01%	2056
2020 Q1	$18K	Hold	170	–	–	﹤0.01%	1914
2019 Q4	$27K	Hold	170	–	–	﹤0.01%	1955
2019 Q3	$25K	Hold	170	–	–	﹤0.01%	1962
2019 Q2	$19K	Hold	170	–	–	﹤0.01%	2033
2019 Q1	$18K	Hold	170	–	–	﹤0.01%	1977
2018 Q4	$13K	Hold	170	–	–	﹤0.01%	2015
2018 Q3	$27K	Buy	+170	New	+$29K	﹤0.01%	2012

Other funds holding VRCA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

STRS Ohio's VRCA Position: Q2 2022 in Review

STRS Ohio sold out of Verrica Pharmaceuticals (VRCA) in Q2 2022, closing a stake of 30 shares — an estimated $2K sold.

STRS Ohio first reported a position in VRCA in Q3 2018 and held it in 15 quarters. The position peaked at $27K in Q4 2019. 57 funds tracked by Wall St. Rank hold VRCA as of Q2 2022.

STRS Ohio reported no remaining Verrica Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 30 Verrica Pharmaceuticals shares in Q2 2022, an estimated $2K.
STRS Ohio first reported a position in Verrica Pharmaceuticals in Q3 2018 and held it in 15 quarters.
STRS Ohio's Verrica Pharmaceuticals position peaked at $27K in Q4 2019.
57 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.